These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23357810)

  • 41. High-throughput screening of peptide deformylase inhibitors.
    Nguyen KT; Pei D
    Methods Mol Med; 2008; 142():117-30. PubMed ID: 18437310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy.
    Fu H; Dahlgren C; Bylund J
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2545-50. PubMed ID: 12878517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iron center, substrate recognition and mechanism of peptide deformylase.
    Becker A; Schlichting I; Kabsch W; Groche D; Schultz S; Wagner AF
    Nat Struct Biol; 1998 Dec; 5(12):1053-8. PubMed ID: 9846875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
    Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
    Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crystallization and preliminary X-ray crystallographic analysis of peptide deformylase from Thermus thermophilus HB8.
    Kamo M; Kudo N; Lee WC; Motoshima H; Tanokura M
    Acta Crystallogr D Biol Crystallogr; 2004 Jul; 60(Pt 7):1299-300. PubMed ID: 15213398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Peptide-deformylase inhibitors, a new class of antibiotics].
    Dubreuil L
    Presse Med; 2002 Nov; 31(38):1810-2. PubMed ID: 12497724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-function relationships within the peptide deformylase family. Evidence for a conserved architecture of the active site involving three conserved motifs and a metal ion.
    Meinnel T; Lazennec C; Villoing S; Blanquet S
    J Mol Biol; 1997 Apr; 267(3):749-61. PubMed ID: 9126850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular cloning and characterization of a new peptide deformylase from human pathogenic bacterium Helicobacter pylori.
    Han C; Wang Q; Dong L; Sun H; Peng S; Chen J; Yang Y; Yue J; Shen X; Jiang H
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1292-8. PubMed ID: 15194508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
    Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
    J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Catalytic mechanism and metal specificity of bacterial peptide deformylase: a density functional theory QM/MM study.
    Xiao C; Zhang Y
    J Phys Chem B; 2007 Jun; 111(22):6229-35. PubMed ID: 17503802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results.
    Pichota A; Duraiswamy J; Yin Z; Keller TH; Alam J; Liung S; Lee G; Ding M; Wang G; Chan WL; Schreiber M; Ma I; Beer D; Ngew X; Mukherjee K; Nanjundappa M; Teo JW; Thayalan P; Yap A; Dick T; Meng W; Xu M; Koehn J; Pan SH; Clark K; Xie X; Shoen C; Cynamon M
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6568-72. PubMed ID: 19008098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Purification and characterization of enzymes involved in the degradation of chemotactic N-formyl peptides.
    Nguyen KT; Pei D
    Biochemistry; 2005 Jun; 44(23):8514-22. PubMed ID: 15938642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteomic study of peptide deformylase inhibition in Streptococcus pneumoniae and Staphylococcus aureus.
    Wang W; White R; Yuan Z
    Antimicrob Agents Chemother; 2006 May; 50(5):1656-63. PubMed ID: 16641432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics.
    Yuan Z; White RJ
    Biochem Pharmacol; 2006 Mar; 71(7):1042-7. PubMed ID: 16289392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Type 3 peptide deformylases are required for oxidative phosphorylation in Trypanosoma brucei.
    Bouzaidi-Tiali N; Giglione C; Bulliard Y; Pusnik M; Meinnel T; Schneider A
    Mol Microbiol; 2007 Sep; 65(5):1218-28. PubMed ID: 17651388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peptide-cleaving catalyst selective for peptide deformylase.
    Chae PS; Kim MS; Jeung CS; Lee SD; Park H; Lee S; Suh J
    J Am Chem Soc; 2005 Mar; 127(8):2396-7. PubMed ID: 15724986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A FRET enzyme-based probe for monitoring hydrogen sulfide.
    Strianese M; Palm GJ; Milione S; Kühl O; Hinrichs W; Pellecchia C
    Inorg Chem; 2012 Nov; 51(21):11220-2. PubMed ID: 23072298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity.
    Somerville GA; Cockayne A; Dürr M; Peschel A; Otto M; Musser JM
    J Bacteriol; 2003 Nov; 185(22):6686-94. PubMed ID: 14594843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acarbose Potentially Binds to the Type I Peptide Deformylase Catalytic Site and Inhibits Bacterial Growth: An
    Singh AK; Prajapati KS; Kumar S
    Curr Pharm Des; 2022; 28(35):2890-2900. PubMed ID: 36154601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mapping of the active site zinc ligands of peptide deformylase.
    Meinnel T; Lazennec C; Blanquet S
    J Mol Biol; 1995 Nov; 254(2):175-83. PubMed ID: 7490741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.